Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 6Neoplasm Metastasis 2Hematologic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Testicular Neoplasms 1Small Cell Lung Carcinoma 1Multiple Myeloma 1Meningioma 1Lymphoma 1Lung Neoplasms 1Leukemia 1Hypogonadism 1Head and Neck Neoplasms 1Cognitive/Functional Effects 1Cognitive Dysfunction 1Breast Neoplasms, Male 1Breast Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

lutetium Lu 177 dotatate 5Magnetic Resonance Spectroscopy 5Specimen Handling 4Radiosurgery 3gallium Ga 68 dotatate 2abemaciclib 2Ga(III)-DOTATOC 2Bevacizumab 2ribociclib 1regorafenib 1pembrolizumab 1olaparib 1neratinib 1capivasertib 1cabozantinib 1brigatinib 1X-Rays 1Watchful Waiting 1Tablets 1Surveys and Questionnaires 1Sunitinib 1Radiotherapy, Intensity-Modulated 1Protons 1Proton Therapy 1Photons 1Observation 1ONC206 1Nivolumab 1Mental Status and Dementia Tests 1Lysine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningioma × Mental Status and Dementia Tests × 90 days × Clear all
NCT06466720 2026-05-04

CoDeB-Rad

University of Nottingham

Active not recruiting
80 enrolled
CNS

Brain Neoplasms, Meningioma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡